Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000071.xml
Download PDF
Semin Neurol 2003; 23(4): 443-452
DOI: 10.1055/s-2004-817728
DOI: 10.1055/s-2004-817728
Evaluation and Treatment of Autonomic Disorders of the Urogenital System
Further Information
Publication History
Publication Date:
15 April 2004 (online)
ABSTRACT
Autonomic pathways are important in the regulation of both lower urinary tract and sexual function, and their interruption in neurological pathologies predictably results in variable urogenital dysfunction, depending mainly on the level of the lesion. A normal neurological examination of a patient with urogenital complaints should exclude an underlying neurological pathology, and the neurologist should become involved in the management of symptoms. Electromyography can be of value in the diagnosis and management of cauda equina lesions and multiple system atrophy, but neurophysiological investigations are of no importance in the diagnosis of neurogenic sexual dysfunction. Urodynamic studies have proven helpful in determining the type and management of lower urinary tract dysfunction. Oral anticholinergics usually combined with clean intermittent catheterizations are the first-line treatment options for neurogenic lower urinary tract dysfunction, with intravesical treatments emerging as the main alternative in intractable incontinence. The availability of effective oral phosphodiesterase inhibitors has revolutionized the management of erectile dysfunction, but treatment of ejaculatory and orgasmic disorders as well as of female sexual dysfunction still remains problematic.
KEYWORDS
Urinary tract - neural control - autonomic neuropathies - overactive bladder - detrusor hyperreflexia - urodynamic - sexual/erectile dysfunction - treatment - sildenafil
REFERENCES
- 1 de Groat W C, Booth A M, Yoshimura N. Neurophysiology of micturition and its modification in animal models of human disease. In: Maggi CA, ed. The Autonomic Nervous System. Vol. 3: Nervous Control of the Urogenital
System. London: Harwood Academic Publishers 1993: 227-290
MissingFormLabel
- 2 Chai T C, Steers W D. Neurophysiology of micturition and continence. Urol Clin North Am . 1996; 23 221-236
- 3 Yoshimura N, de Groat W C. Neural control of the lower urinary tract. Int J Urol . 1997; 4 111-125
- 4 de Groat W C, Downie J W, Levin R M. Basic neurophysiology and neuropharmacology. In: Abrams P, Khoury S, Wein AJ, eds. Incontinence: 1st International Consultation
on Incontinence Plymouth, UK: Plymbridge Distributors Ltd 1999: 105-154
MissingFormLabel
- 5 Dixon J S, Gilpin C J. Presumptive sensory axons of the human urinary bladder: a fine structural study. J Anat . 1987; 151 199-207
- 6 de Groat C W, Nadelhaft I, Milne R J, Booth A M, Morgan C, Thor K. Organization of the sacral parasympathetic reflex pathways to the urinary bladder and large intestine. J Auton Nerv Syst . 1981; 3 135-160
- 7 Mallory B, Steers W D, de Groat C W. Electrophysiological study of micturition reflexes in rats. Am J Physiol . 1989; 257 R410-R421
- 8 Vera P L, Nadelhaft I. Conduction velocity distribution of afferent nerves innervating the rat urinary bladder. Brain Res . 1990; 520 83-89
- 9 Andersson K-E. Bladder activation: afferent mechanisms. Urology . 2002; 59(Suppl. 1) 43-50
- 10 Janig W, McLachlan E M. Organization of lumbar spinal outflow to distal colon and pelvic organs. Physiol Rev . 1987; 67 1332-1404
- 11 Lundberg J M. Pharmacology of cotransmission in the autonomic nervous system: integrative aspects on amines neuropeptides, adenosine triphosphate, amine acids and nitric oxide. Pharmacol Rev . 1996; 48 113-178
- 12 Thornbury K D, Hollywood M A, McHale N G. Mediation by nitric oxide of neurogenic relaxation of the urinary bladder neck muscle in sheep. J Physiol . 1992; 451 133-144
- 13 Andersson K-E. Pharmacology of lower urinary tract smooth muscles and penile erectile tissues. Pharmacol Rev . 1993; 45 253-308
- 14 Bennett B C, Roppolo J R, Kruse M N, de Groat C W. Neural control of urethral smooth and striated muscle activity in vivo: role of nitric oxide. J Urol . 1995; 153 2004-2009
- 15 Takeda M, Lepor H. Nitric oxide synthase in the dog urethra: a histochemical and pharmacological analysis. Br J Pharmacol . 1995; 116 2517-2523
- 16 de Groat W C, Booth A M. Synaptic transmission in pelvic ganglia. In: Maggi CA, ed. The Autonomic Nervous System Vol. 3: Nervous Control of the Urogenital
System. London: Harwood Academic Publishers 1993: 291-347
MissingFormLabel
- 17 Yoshimura N. Bladder afferent pathway and spinal cord injury: possible mechanisms inducing hyperreflexia of the urinary bladder. Prog Neurobiol . 1999; 57 583-606
- 18 Lundberg P, Brattberg A. Impotence-the neurological risk factor. Int J Impot Res . 1993; 5 241-243
- 19 Lue T F, Tanagho E A. Physiology of erection and pharmacological management of impotence. J Urol . 1987; 137 829-836
- 20 Ignarro L J, Bush P A, Buga G M. et al . Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle. Biochem Biophys Res Commun . 1990; 170 843-850
- 21 Kim N, Azadzoi K M, Goldstein I, Saenz de Tejada I. A nitric oxide-like factor mediates nonadrenergic-noncholinergic neurogenic relaxation of penile corpus cavernosum smooth muscle. J Clin Invest . 1991; 88 112-118
- 22 Lue T F. Physiology of penile erection and pathophysiology of erectile dysfunction and priapism. In: Walsh PC, Retik AB, Darracott Vaughan E Jr, Wein AJ, eds. Campbell's Urology Philadelphia: WB Saunders 1998: 1157-1179
MissingFormLabel
- 23 de Groat W C, Booth A . Neural control of penile erection. In: Maggi CA, ed. The Autonomic Nervous System Vol. 3: Nervous Control of the Urogenital
System. London: Harwood Academic Publishers 1993: 465-513
MissingFormLabel
- 24 Hoyle C HV, Lincoln J, Burnstock G. Neural control of pelvic organs. In: Rushton DN, ed. Handbook of Neuro-Urology New York: Marcel Dekker 1994: 1-54
MissingFormLabel
- 25 Lundberg P. Physiology of female sexual function and how it is affected in neurological disease. In: Fowler CJ, ed. Neurology of Bladder, Bowel and Sexual Dysfunction Newton, MA: Butterworth Heinemann 1999: 33-46
MissingFormLabel
- 26 Abrams P, Cardozo L, Fall M. et al . The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn . 2002; 21 167-178
- 27 Kruse M N, Belton A L, deGroat C W. Changes in bladder and external urethral sphincter function after spinal cord injury in the rat. Am J Physiol . 1993; 264(6 Pt 2) R1157-R1163
- 28 Yoshimura N, Erdman S L, Snider M W, de Groat C W. Effects of spinal cord injury on neurofilament immunoreactivity and capsaicin sensitivity in rat dorsal root ganglion neurons innervating the urinary bladder. Neuroscience . 1998; 83 633-643
- 29 Brady C M, Apostolidis A, Harper M. et al . Parallel changes in bladder suburothelial vanilloid receptor TRPV1 (VR1) and pan-neuronal marker PGP9.5 immunoreactivity in patients with neurogenic detrusor overactivity (NDO) following intravesical resiniferatoxin treatment (in press). BJU Int 2004.
- 30 Brady C, Apostolidis A, Yiangou Y. et al . P2X3-immunoreactive nerve fibres in neurogenic detrusor overactivity and the effect of intravesical resiniferatoxin (RTX) (in press). Eur Urol. 2004;
- 31 Chandiramani V A, Fowler C J. Urogenital disorders in Parkinson's disease and multiple system atrophy. In: Fowler CJ, ed. Neurology of Bladder, Bowel and Sexual Dysfunction Woburn, MA: Butterworth-Heinemann 1999: 245-254
MissingFormLabel
- 32 Yoshimura N, Mizuta E, Kuno S, Sasa M, Yoshida O. The dopamine D1 receptor agonist SKF 38393 suppresses detrusor hyperreflexia in the monkey with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Neuropharmacology . 1993; 32 315-321
- 33 Fitzmaurice H, Fowler C J, Rickards D. et al . Micturition disturbance in Parkinson's disease. Br J Urol . 1985; 57 652-656
- 34 Christmas T J, Kempster P A, Chapple C R. et al . Role of subcutaneous apomorphine in parkinsonian voiding dysfunction. Lancet . 1988; 2 1451-1453
- 35 Aranda B, Cramer P. Effects of apomorphine and L-dopa on the parkinsonian bladder. Neurourol Urodyn . 1993; 12 203-209
- 36 Yamamoto M. Pergolide improves neurogenic bladder in patients with Parkinson's disease. Mov Disord . 1997; 12 (suppl 1) P328
- 37 Quinn N. Parkinsonism-recognition and differential diagnosis. BMJ . 1995; 310 447-452
- 38 Kirby R S, Fowler C J, Gosling J A, Bannister R. Urethro-vesical dysfunction in progressive autonomic failure with multiple system atrophy. J Neurol Neurosurg Psychiatry . 1986; 49 554-562
- 39 Chandiramani V A, Palace J, Fowler C J. How to recognize patients with parkinsonism who should not have urological surgery. Br J Urol . 1997; 80 100-104
- 40 Beck R, Betts C D, Fowler C J. Genitourinary dysfunction in multiple system atrophy: clinical features and treatment in 62 cases. J Urol . 1994; 151 1336-1341
- 41 Sakakibara R, Hattori T, Uchiyama T. et al . Urinary dysfunction and orthostatic hypotension in multiple system atrophy: which is the more common and earlier manifestation?. J Neurol Neurosurg Psychiatry . 2000; 68 65-69
- 42 Kirchhof K, Apostolidis A, Mathias C J, Fowler C J. Erectile and urinary dysfunction may be the presenting features in patients with multiple system atrophy: a retrospective study. Int J Impot Res . 2003; 15 293-298
- 43 Frimodt-Moller C. Diabetic cystopathy. A review of the urodynamic and clinical features of neurogenic bladder dysfunction in diabetes mellitus. Dan Med Bull . 1978; 25 49-60
- 44 Gertz M A, Kyle R A. Amyloidosis: prognosis and treatment. Semin Arthritis Rheum . 1994; 24 124-138
- 45 Kogan B A, Solomon M H, Diokno A C. Urinary retention secondary to Landry-Guillain-Barre syndrome. J Urol . 1981; 126 643-644
- 46 Kaplan S A, Te A E, Blaivas J G. Urodynamic findings in patients with diabetic cystopathy. J Urol . 1995; 153 342-344
- 47 Mundy A R. An anatomical explanation for bladder dysfunction following rectal and uterine surgery. Br J Urol . 1982; 54 501-504
- 48 Dasgupta P, Thomas P K. Peripheral neuropathy. In: Fowler CJ, ed. Neurology of Bladder, Bowel and Sexual Dysfunction Woburn, MA: Butterworth-Heinemann 1999: 339-352
MissingFormLabel
- 49 Pang D, Wilberger Jr. E J. Tethered cord syndrome in adults. J Neurosurg . 1982; 57 32-47
- 50 Mathew P, Todd N V. Intradural conus and cauda equina tumours: a retrospective review of presentation, diagnosis and early outcome. J Neurol Neurosurg Psychiatry . 1993; 56 69-74
- 51 Hussain I F. Cauda equina damage and its management. In: Fowler CJ, ed. Neurology of Bladder, Bowel and Sexual Dysfunction Woburn, MA: Butterworth-Heinemann 1999: 325-337
MissingFormLabel
- 52 Azadzoi K M, deTejada I S. Diabetes mellitus impairs neurogenic and endothelium-dependent relaxation of rabbit corpus cavernosum smooth muscle. J Urol . 1992; 148 1587-1591
- 53 Kolodny R C, Kahn C B, Goldstein H H, Barnett D M. Sexual dysfunction in diabetic men. Diabetes . 1974; 23 306-309
- 54 Jensen S B. The natural history of sexual dysfunction in diabetic women. A 6-year follow-up study. Acta Med Scand . 1986; 219 73-78
- 55 Finkle A L, Taylor S P. Sexual potency after radical prostatectomy. J Urol . 1981; 125 350-352
- 56 Walsh P C, Donker P J. Impotence following radical prostatectomy: insight into etiology and prevention. J Urol . 1982; 128 492-497
- 57 Quinlan D M, Epstein J I, Carter B S, Walsh P C. Sexual function following radical prostatectomy: influence of preservation of neurovascular bundles. J Urol . 1991; 145 998-1002
- 58 Weinstein M N, Roberts M. Sexual potency following surgery for rectal carcinoma. A follow-up of 44 patients. Ann Surg . 1977; 185 295-300
- 59 Yeager E S, Van Heerden A J. Sexual dysfunction following proctocolectemy and abdominoperineal resection. Ann Surg . 1980; 191 169-170
- 60 Comarr A E, Vigue M. Sexual counseling among male and female patients with spinal cord and/or cauda equina injury. Part II. Results of interview and neurological examinations of females. Am J Phys Med . 1978; 57 215-227
- 61 Comarr A E, Vigue M. Sexual counseling among male and female patients with spinal cord and/or cauda equina injury. Am J Phys Med . 1978; 57 107-122
- 62 Hulter B M, Lundberg P O. Sexual function in women with advanced multiple sclerosis. J Neurol Neurosurg Psychiatry . 1995; 59 83-86
- 63 Singer C, Weiner W J, Sanchez-Ramos J, Ackerman M. Sexual function in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry . 1991; 54 942
- 64 Swinn M J. Urodynamics. In: Fowler CJ, ed. Neurology of Bladder, Bowel and Sexual Dtsfunction Woburn, MA: Butterworth-Heinemann 1999: 97-107
MissingFormLabel
- 65 Fowler C J. Clinical Neurophysiology. Paris: Health Publication Ltd 2002
MissingFormLabel
- 66
Palace J, Chandiramani V A, Fowler C J.
Value of sphincter EMG in the diagnosis of multiple system atrophy.
Muscle Nerve .
1997;
20
1396-1403
MissingFormLabel
- 67 Berger Y, Blaivas J G, DeLaRocha E R, Salinas J M. Urodynamic findings in Parkinson's disease. J Urol . 1987; 138 836-838
- 68 Pramstaller P P, Wenning G K, Smith S J, Beck R O, Quinn N P, Fowler C J. Nerve conduction studies, skeletal muscle EMG, and sphincter EMG in multiple system atrophy. J Neurol Neurosurg Psychiatry . 1995; 58 618-621
- 69 Rodi Z, Denislic M, Vodusek D. External anal sphincter electromyography in the differential diagnosis of parkinsonism. J Neurol Neurosurg Psychiatry . 1996; 60 460-461
- 70 Vodusek D B. Sphincter EMG and differential diagnosis of multiple system atrophy. Mov Disord . 2001; 16 600-607
- 71 Beck R O. Investigation of male erectile dysfunction. In: Fowler CJ, ed. Neurology of Bladder, Bowel and Sexual Dysfunction Woburn, MA: Butterworth-Heinemann 1999: 145-160
MissingFormLabel
- 72 Fowler C J, Ali Z, Kirby R S, Pryor J P. The value of testing for unmyelinated fibre, sensory neuropathy in diabetic impotence. Br J Urol . 1988; 61 63-67
- 73 Cohen M S, Wall E J, Kerber C W, Abitbol J J, Garfin S R. The anatomy of the cauda equina on CT scans and MRI. J Bone Joint Surg Br . 1991; 73 381-384
- 74 Fowler C J. Investigation of the neurogenic bladder. J Neurol Neurosurg Psychiatry . 1996; 60 6-13
- 75 Webb R J, Lawson A L, Neal D E. Clean intermittent self-catheterisation in 172 adults. Br J Urol . 1990; 65 20-23
- 76 Hilton P, Hertogs K, Stanton S L. The use of desmopressin (DDAVP) for nocturia in women with multiple sclerosis. J Neurol Neurosurg Psychiatry . 1983; 46 854-855
- 77 Hoverd P A, Fowler C J. Desmopressin in the treatment of daytime urinary frequency in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry . 1998; 65 778-780
- 78 Brady C M, DasGupta R, Wiseman O J, Dalton C M, Berkley K J, Fowler C J. The effect of cannabis based medicinal extract on lower urinary tract dysfunction in advanced multiple sclerosis: preliminary results. J Neurol Neurosurg Psychiatry . 2002; 72 139
- 79 Schurch B, Stohrer M, Kramer G, Schmid D M, Gaul G, Hauri D. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs?. Preliminary results. . J Urol 2000; 164(3 Pt 1) 692-697
- 80 Reitz A, Stöhrer M, Kramer G. et al . European experience of 200 cases treated with Botulinum-A toxin injections into the detrusor muscle for neurogenic incontinence. Eur Urol . 2003; 2 (suppl 1) 140
- 81 Schumacher S, Haferkamp A, Müller S C. Therapy of neurogenic and non neurogenic detrusor overactivity with detrusor-injections of Botulinum A toxin and continent vesicostomy. Eur Urol . 2003; 2 (suppl 1) 141
- 82 Grosse J O, Kramer A EJL, Löchner-Ernst D, Stöhrer M. Success of repeat detrusor injections of Botulinum A toxin in patients with severe neurogenic detrusor overactivity and incontinence. Eur Urol . 2003; 2 (suppl 1) 141
- 83 Popat R, Harper M, DasGupta R, Fowler C J, Dasgupta P. A minimally invasive technique for outpatient local anaesthetic administration of intradetrusor botulinum toxin in intractable detrusor overactivity. BJU Int . 2003; 92 325-326
- 84 Fowler C J, Beck R O, Gerrard S, Betts C D, Fowler C G. Intravesical capsaicin for treatment of detrusor hyperreflexia. J Neurol Neurosurg Psychiatry . 1994; 57 169-173
- 85 Lazzeri M, Spinelli M, Beneforti P, Zanollo A, Turini D. Intravesical resiniferatoxin for the treatment of detrusor hyperreflexia refractory to capsaicin in patients with chronic spinal cord diseases. Scand J Urol Nephrol . 1998; 32 331-334
- 86 Cruz F. Vanilloid receptor and detrusor instability. Urology . 2002; 59(Suppl. 1) 51-60
- 87 Getliffe K. Catheter and catheterization. In: Getliffe K, Dolman M, eds. Promoting Continence: A Clinical and Research Resource London: Bailliere Tindall 1997: 281-341
MissingFormLabel
- 88 Eckford S B, Kohler-Ockmore J, Feneley R C. Long-term follow-up of transvaginal urethral closure and suprapubic cystostomy for urinary incontinence in women with multiple sclerosis. Br J Urol . 1994; 74 319-321
- 89 MacDiarmid S A, Arnold E P, Palmer N B, Anthony A. Management of spinal cord injured patients by indwelling suprapubic catheterization. J Urol . 1995; 154(2 Pt 1) 492-494
- 90 Brindley G S. The first 500 patients with sacral anterior root stimulator implants: general description. Paraplegia . 1994; 32 795-805
- 91 Bemelmans B L, Mundy A R, Craggs M D. Neuromodulation by implant for treating lower urinary tract symptoms and dysfunction. Eur Urol . 1999; 36 81-91
- 92 Castelo-Branco C, Blumel J E, Araya H. et al . Prevalence of sexual dysfunction in a cohort of middle-aged women: influences of menopause and hormone replacement therapy. J Obstet Gynaecol . 2003; 23 426-430
- 93 DasGupta R, Wiseman O J, Kanabar G, Fowler C J. Efficacy of sildenafil in the treatment of female sexual dysfunction due to multiple sclerosis. J Urol . 2004; 171 1189-1193
- 94 Hatzichristou D G. Sildenafil citrate: lessons learned from 3 years of clinical experience. Int J Impot Res . 2002; 14(Suppl. 1) S43-S52
- 95 Boulton A J, Selam J L, Sweeney M, Ziegler D. Sildenafil citrate for the treatment of erectile dysfunction in men with Type II diabetes mellitus. Diabetologia . 2001; 44 1296-1301
- 96 Incrocci L, Koper P C, Hop W C, Slob A K. Sildenafil citrate (Viagra) and erectile dysfunction following external beam radiotherapy for prostate cancer: a randomized, double-blind, placebo-controlled, cross-over study. Int J Radiat Oncol Biol Phys . 2001; 51 1190-1195
- 97 Guay A T, Perez J B, Jacobson J, Newton R A. Efficacy and safety of sildenafil citrate for treatment of erectile dysfunction in a population with associated organic risk factors. J Androl . 2001; 22 793-797
- 98 Derry F A, Dinsmore W W, Fraser M. et al . Efficacy and safety of oral sildenafil (Viagra) in men with erectile dysfunction caused by spinal cord injury. Neurology . 1998; 51 1629-1633
- 99 Sanchez Ramos A, Vidal J, Jauregui M L. et al . Efficacy, safety and predictive factors of therapeutic success with sildenafil for erectile dysfunction in patients with different spinal cord injuries. Spinal Cord . 2001; 39 637-643
- 100 Fowler C J, Miller J, Sharief M. Viagra (sildenafil citrate) for the treatment of erectile dysfunction in men with multiple sclerosis (in press). 2002;
- 101 Hussain I, Brady C, Swinn M, Mathias C, Fowler C J. Treatment with sildenafil citrate (Viagra) of erectile dysfunction in parkinsonism due to Parkinson's disease or multiple system atrophy and the risk of exacerbating orthostatic hypotension. J Neurol Neurosurg Psychiatry . 2001; 71 371-374
- 102 Kim N N. Phosphodiesterase type 5 inhibitors: a biochemical and clinical correlation survey. Int J Impot Res . 2003; 15(Suppl. 5) S13-S19
- 103 Montorsi F, Salonia A, Deho' F. et al . Pharmacological management of erectile dysfunction. BJU Int . 2003; 91 446-454
- 104 Linet O I, Neff L L. Intracavernous prostaglandin E1 in erectile dysfunction. Clin Investig . 1994; 72 139-149
- 105 Lue T F, Broderick G. Evaluation and nonsurgical management of erectile dysfunction and priapism. In: Walsh PC, Retik AB, Darracott Vaughan E Jr, Wein AJ, eds. Campbell's Urology Philadelphia: WB Saunders 1998: 1181-1214
MissingFormLabel
- 106 Guay A T, Perez J B, Velasquez E, Newton R A, Jacobson J P. Clinical experience with intraurethral alprostadil (MUSE) in the treatment of men with erectile dysfunction. A retrospective study. Medicated urethral system for erection. Eur Urol . 2000; 38 671-676
- 107 Cookson M S, Nadig P W. Long-term results with vacuum constriction device. J Urol . 1993; 149 290-294
- 108 Ellenberg M, Weber H. Retrograde ejaculation in diabetic neuropathy. Ann Intern Med . 1966; 65 1237-1246
- 109 Nehra A, Werner M A, Bastuba M, Title C, Oates R D. Vibratory stimulation and rectal probe electroejaculation as therapy for patients with spinal cord injury: semen parameters and pregnancy rates. J Urol . 1996; 155 554-559
- 110 Sonksen J, Ohl D A. Penile vibratory stimulation and electroejaculation in the treatment of ejaculatory dysfunction. Int J Androl . 2002; 25 324-332